Hormone replacement therapy (HRT) products could be shipped from Poland and other European countries from next week to help fill the UK shortage.
Major HRT providers have announced that they are preparing to launch products as a short-term solution while addressing longer-term supply issues.
More than a million women in the UK are currently using some form of HRT, which helps manage the symptoms of menopause by boosting estrogen and other hormones.
The shortage is attributed to increased demand due to media coverage of menopause and general supply chain issues.
Now the drug’s suppliers say they are “assessing all options to increase near-term supply.”
Theramex – which makes around 12 different HRT drugs, including Bijuva pills and Femseven patches – say they are working on getting a special permit to import products from France.
Tina Backhouse, the general UK manager at Theramex, narrated The guard They work with the Drugs and Healthcare Products Regulatory Agency to obtain this approval.
“We’re looking at both short-term and longer-term solutions to introduce other products from other countries,” she said.
The shortages have mainly affected the supply of Estogel – one of the most popular HRT drugs manufactured by Besins Healthcare. A company representative said it was “assessing all options to increase near-term supplies of estrogel to the UK”.
Doctors and women’s health experts have welcomed the new short-term fix and more government support amid the shortage.
dr Shirin Lakhani, physician and women’s health advocate, said: “The symptoms of menopause can be debilitating and include anxiety and insomnia. So many women rely on HRT and have difficulty accessing certain medications.
“HRT is not a luxury, but it is treated as such. There is a perception that not taking HRT for a while is not a big deal, but that is very wrong. The impact on a woman’s mental health is enormous.
“We need to listen to women”